Wire · technology
TCS launches agentic AI platform for drug development
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 17 August 2026 · Fusion42 review
TCS has launched TCS ADD AgentHub, an agentic AI platform that helps pharmaceutical companies improve efficiency in drug development and pharmacovigilance with integrated AI agents supporting clinical workflows and regulatory compliance.
This Wire brief sits within Fusion42's coverage of AI Agents, Drug Discovery and Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.
◆ ◆ The Wire takeaway
You can deploy AI agents alongside your team to cut clinical data management time and costs without overhauling existing systems. This new platform makes AI integration in pharma workflows practical and compliant with tough regulations.
◆ Related on Wire
◆ Topics